Reliability of automated biochemical identification of Burkholderia pseudomallei is regionally dependent

Journal of Clinical Microbiology

Volumn 51, Issue 9, 2013, Pages 3076-3078

  Podin, Yuwana ^a,b   Kaestli, Mirjam ^a   McMahon, Nicole ^c   Hennessy, Jann ^c   Ngian, Hie Ung ^d   Wong, Jin Shyan ^e   Mohana, Anand ^e   Wong, See Chang ^f   William, Timothy ^g   Mayo, Mark ^a   Baird, Robert W ^c   Currie, Bart J ^a,c  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b UNIVERSITI MALAYSIA SARAWAK   (Malaysia)

^c ROYAL DARWIN HOSPITAL   (Australia)

^d Kapit Hospital   (Malaysia)

^e Bintulu Hospital   (Malaysia)

^f Sibu Hospital   (Malaysia)

^g Queen Elizabeth Hospital   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLGALACTOSAMINIDASE; N ACETYL BETA GLUCOSAMINIDASE;

ANALYTICAL EQUIPMENT; ARTICLE; AUSTRALIA; AUTOMATED BIOCHEMICAL IDENTIFICATION SYSTEM; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIOCHEMISTRY; BURKHOLDERIA PSEUDOMALLEI; CLINICAL ARTICLE; CONTROLLED STUDY; GEOGRAPHICAL VARIATION (SPECIES); HUMAN; LATEX AGGLUTINATION TEST; MALAYSIA; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; SPECIES IDENTIFICATION;

AUSTRALIA; AUTOMATION, LABORATORY; BACTERIAL TYPING TECHNIQUES; BURKHOLDERIA PSEUDOMALLEI; DIAGNOSTIC ERRORS; GEOGRAPHY; HUMANS; MALAYSIA; SENSITIVITY AND SPECIFICITY;

EID: 84882775813     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01290-13     Document Type: Article

References (21)

1. Wiersinga WJ, Currie BJ, Peacock SJ. 2012. Melioidosis. N. Engl. J. Med. 367:1035-1044.
2. Cheng AC, Currie BJ. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18:383-416. (Erratum, 20:533, 2007.)
3. Dance DA, Wuthiekanun V, Naigowit P, White NJ. 1989. Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE. J. Clin. Pathol. 42:645-648.
4. Hodgson K, Engler C, Govan B, Ketheesan N, Norton R. 2009. Comparison of routine bench and molecular diagnostic methods in identification of Burkholderia pseudomallei. J. Clin. Microbiol. 47:1578-1580.
5. Lowe P, Engler C, Norton R. 2002. Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei. J. Clin. Microbiol. 40:4625-4627.
6. Lowe P, Haswell H, Lewis K. 2006. Use of various common isolation media to evaluate the new VITEK 2 colorimetric GN card for identification of Burkholderia pseudomallei. J. Clin. Microbiol. 44:854-856.
7. Koh TH, Yong Ng LS, Foon Ho JL, Sng LH, Wang GC, Tzer Pin Lin RV. 2003. Automated identification systems and Burkholderia pseudomallei. J. Clin. Microbiol. 41:1809.
8. Zong Z, Wang X, Deng Y, Zhou T. 2012. Misidentification of Burkholderia pseudomallei as Burkholderia cepacia by the VITEK 2 system. J. Med. Microbiol. 61:1483-1484.
9. Weissert C, Dollenmaier G, Rafeiner P, Riehm J, Schultze D. 2009. Burkholderia pseudomallei misidentified by automated system. Emerg. Infect. Dis. 15:1799-1801. doi:10.3201/eid1511.081719.
10. Novak RT, Glass MB, Gee JE, Gal D, Mayo MJ, Currie BJ, Wilkins PP. 2006. Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei. J. Clin. Microbiol. 44:85-90.
11. Kaestli M, Richardson LJ, Colman RE, Tuanyok A, Price EP, Bowers JR, Mayo M, Kelley E, Seymour ML, Sarovich DS, Pearson T, Engelthaler DM, Wagner DM, Keim PS, Schupp JM, Currie BJ. 2012. Comparison of TaqMan PCR assays for detection of the melioidosis agent Burkholderia pseudomallei in clinical specimens. J. Clin. Microbiol. 50:2059-2062.
12. Anuntagool N, Naogowit P, Petkanchanapong V, Aramsri P, Panichakul T, Sirisinha S. 2000. Monoclonal antibody-based rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia. J. Med. Microbiol. 49:1075-1078.
13. Dubois D, Grare M, Prere MF, Segonds C, Marty N, Oswald E. 2012. Performances of the VitekMSmatrix-assisted laser desorption ionizationtime of flight mass spectrometry system for rapid identification of bacteria in routine clinical microbiology. J. Clin. Microbiol. 50:2568-2576.
14. Coenye T, Vandamme P, LiPuma JJ, Govan JR, Mahenthiralingam E. 2003. Updated version of the Burkholderia cepacia complex experimental strain panel. J. Clin. Microbiol. 41:2797-2798.
15. Vandamme P, Dawyndt P. 2011. Classification and identification of the Burkholderia cepacia complex: past, present and future. Syst. Appl. Microbiol. 34:87-95.
16. Gilad J, Giladi M, Schwartz D. 2007. Candida albicans masquerading as Gram-negative bacilli in the clinical laboratory. Scand. J. Infect. Dis. 39: 907-910.
17. Burton MJ, Shah P, Swiatlo E. 2011. Misidentification of Candida parapsilosis as C. famata in a clinical case of vertebral osteomyelitis. Am. J. Med. Sci. 341:71-73.
18. Yakandawala N, Gawande PV, LoVetri K, Cardona ST, Romeo T, Nitz M, Madhyastha S. 2011. Characterization of the poly-1, 6-Nacetylglucosamine polysaccharide component of Burkholderia biofilms. Appl. Environ. Microbiol. 77:8303-8309.
19. Masoud H, Ho M, Schollaardt T, Perry MB. 1997. Characterization of the capsular polysaccharide of Burkholderia (Pseudomonas) pseudomallei 304b. J. Bacteriol. 179:5663-5669.
20. Cuccui J, Milne TS, Harmer N, George AJ, Harding SV, Dean RE, Scott AE, Sarkar-Tyson M, Wren BW, Titball RW, Prior JL. 2012. Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region. Infect. Immun. 80:1209-1221.
21. Tuanyok A, Leadem BR, Auerbach RK, Beckstrom-Sternberg SM, Beckstrom-Sternberg JS, Mayo M, Wuthiekanun V, Brettin TS, Nierman WC, Peacock SJ, Currie BJ, Wagner DM, Keim P. 2008. Genomic islands from five strains of Burkholderia pseudomallei.BMCGenomics. 9:566. doi: 10.1186/1471-2164-9-566.